Philogen Stock Quote PHIL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

27.10

Bid

26.80

Ask

27.50

Volume

136,843

27.00 Day's Range 27.60

16.50 52 Week Range 27.80

Market Cap

1.095B

Previous Close

27.40

Open

27.00

Last Trade

27.1

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

11,680

Shares Outstanding

40,397,605

Dividend Yield

PE Ratio

0.00

Earnings Per Share (EPS)

Revenue

25.12M

Net Profit

-6.16M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.philogen.com

Headquarters

Siena, Siena, Ita

Founded

Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 27.40 €. Over the last year, Philogen shares have traded in a share price range of 16.50 € to 27.80 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 1.11 € billion.

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting...

Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

Consideration composed of a $350m up-front payment and up to $1.0bn in development, regulatory and commercial milestones, along with mid-single to...

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients...

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by...

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for...

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful...

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii...

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in...

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	4.6	20.4444444444	22.5	27.8	22.4	37112	26.35765728	DE
4	4.2	18.3406113537	22.9	27.8	21.7	16043	24.71702197	DE
12	8.25	43.7665782493	18.85	27.8	18.35	11680	22.76848907	DE
26	8.45	45.308310992	18.65	27.8	16.5	8585	21.07273482	DE
52	6.6	32.1951219512	20.5	27.8	16.5	7495	20.64423766	DE
156	12.7	88.1944444444	14.4	27.8	13	8655	17.93461275	DE
260	10.1	59.4117647059	17	27.8	12.6	11813	16.41265885	DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?

The current share price of Philogen is 27.10 €

How many Philogen shares are in issue?

Philogen has 40,397,605 shares in issue

What is the market cap of Philogen?

The market capitalisation of Philogen is EUR 1.11B

What is the 1 year trading range for Philogen share price?

Philogen has traded in the range of 16.50 € to 27.80 € during the past year

What is the reporting currency for Philogen?

Philogen reports financial results in EUR

What is the latest annual turnover for Philogen?

The latest annual turnover of Philogen is EUR 25.12M

What is the latest annual profit for Philogen?

The latest annual profit of Philogen is EUR -6.16M

What is the registered address of Philogen?

The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100

What is the Philogen website address?

The website address for Philogen is www.philogen.com

Which industry sector does Philogen operate in?

Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WNUS26Nusco Spa	0.084 € (29.23%)	2k
FFFFinance for Food SpA Societa Benefit	2.06 € (12.57%)	112.8k
RMTRiba Mundo Tecnologia SA	3.04 € (10.95%)	6.8k
GSPGas Plus Spa	4.92 € (8.13%)	443.98k
1ASTSAST SpaceMobile Inc	34.20 € (7.55%)	94
WAGAINWarr Cloudia Research 2325	0.0004 € (-87.10%)	10.31k
AATAAAA Tech SpA	0.0005 € (-83.33%)	470.7k
WFTC26Finanzatech Spa	0.004 € (-66.39%)	500
WTWL26TraWell Co SpA	0.17 € (-41.18%)	25.8k
WINC26Innovatec SpA	0.0551 € (-14.04%)	3.25k
TITTelecom Italia SpA	0.375 € (-2.27%)	157.03M
ISPIntesa Sanpaolo Spa	4.8215 € (-0.79%)	86.36M
SPMSaipem Spa	2.345 € (-2.13%)	82.45M
FDAFidia	0.0052 € (-5.45%)	58.62M
IGAAItalgas SpA	0.4862 € (5.70%)	31.14M